NCT07377643 2026-02-25IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast CancerInnovent Biopharmaceutical Technology (Hangzhou) Co., LTD.Phase 3 Recruiting540 enrolled